Stock Price
17.44
Daily Change
-0.06 -0.34%
Monthly
-3.27%
Yearly
3.20%
Q1 Forecast
16.77

Adma Biologics reported $402.66M in Current Assets for its fiscal quarter ending in September of 2025.





Current Assets Change Date
Adma Biologics USD 402.66M 3.1M Sep/2025
Alnylam Pharmaceuticals USD 3.95B 309.11M Sep/2025
Dynavax Technologies USD 814.33M 28.62M Sep/2025
Takeda JPY 3.12T 195.82B Dec/2025